Ushbu ish iqtibos qilgan ishlar

302 ta ish

Ish: Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment

1. Epithelial and endothelial mesenchymal transition and their role in diabetic kidney disease

   Farahnaz Dadras, Vida Sheikh, Farhad Khoshjou

   Maqola20172 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.047724

2. RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer

   Xinbing Sui, Ruonan Zhang, Shuiping Liu +8

   Maqola20182 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.047735

3. Oncolytic Viruses and the Immune System: The Dynamic Duo

   Ana Lemos de Matos, Lina S. Franco, Grant McFadden

   Sharh maqola20202 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.047760

4. Factors associated with delayed diagnosis of breast cancer; a study in North-West of Iran

   Nasrin Fouladi, Maedeh Barahman, Firouz Amani +2

   Maqola20192 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.047765

5. The emerging molecular mechanism of m6A modulators in tumorigenesis and cancer progression

   Shuiping Liu, Qiujie Li, Ke Chen +7

   Sharh maqola20202 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.047769

6. <p>Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review</p>

   Jie Li, Jiaqian Zhao, Tiantian Tan +7

   Sharh maqola20202 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.047770

7. Efficient isolation and identification of primary endothelial cells from bovine aorta by collagenase P

   Faezeh Seif, Alireza Kheirollah, Hossein Babaahmadi‐Rezaei

   Maqola20202 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.047774

8. Relation between Immune cell response and stemness genes expression in breast cancer; A new approach in NANOG gene and Let7-a expression in breast cancer cell lines

   Zeynab Aliyari-Serej, Ayyub Ebrahımı, Tohid Kazemi +4

   Maqola20202 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.047776

9. Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective

   Yuan Gao, Hang Zhang, Frédéric Lirussi +3

   Sharh maqola20202 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.047779

10. Prevalence of Malignancy and Chronic Obstructive Pulmonary Disease among Patients with COVID-19: A Systematic Review and Meta-analysis

    Somaye Jamali, Cicilia Marcella, Pallavi Prakash +2

    Sharh maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047780

11. Small molecule DNA-PK inhibitors as potential cancer therapy: a patent review (2010–present)

    Suwen Hu, Zi Hui, Frédéric Lirussi +3

    Sharh maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047783

12. MgFe‐LDH Nanoparticles: A Promising Leukemia Inhibitory Factor Replacement for Self‐Renewal and Pluripotency Maintenance in Cultured Mouse Embryonic Stem Cells

    Xiaolie He, Yanjing Zhu, Li Yang +6

    Maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047786

13. Prognostic implication of PD-L1 expression and associated tumor infiltrating lymphocytes in metastatic breast cancer

    Mohamed M Darwish, Atef Youssef Riad, Dina Salem +3

    Maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047798

14. Lung cancer risk and the inhibitors of angiotensin converting enzyme; an updated review on recent evidence

    Maryam Khosravian, Mahnaz Momenzadeh, Farzad Koosha +2

    Maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047799

15. The regulatory role of autophagy-related miRNAs in lung cancer drug resistance

    Mahshid Shahverdi, Khalil Hajiasgharzadeh, Amin Daei Sorkhabi +9

    Sharh maqola20222 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047809

16. RETRACTED: Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies

    Navid Shomali, Marwah Suliman Maashi, Behzad Baradaran +7

    Sharh maqola20222 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047810

17. The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme

    Amin Daei Sorkhabi, Aila Sarkesh, Hossein Saeedi +5

    Sharh maqola20222 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047812

18. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047814

19. Cancer combination therapies by silencing of CTLA‐4, PD‐L1, and TIM3 in osteosarcoma

    Amin Daei Sorkhabi, Aila Sarkesh, Ali Fotouhi +2

    Maqola20222 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047818

20. Evaluation of the urine mRNA-PCA3 expression level in prostate patients; comparison between benign prostatic hyperplasia and cancer

    Amid Yazdani, Farshad Namdari, Sattar Gorgani‐Firuzjaee +1

    Maqola20222 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047819

21. Survival rates and prognostic factors of thyroid cancer: A retrospective cohort study

    Ali Amri, Ali Reza Soltanian, Shiva Borzouei

    Maqola20222 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047824

22. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047530

23. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047531

24. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047532

25. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047533